Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
株式のランク #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
株価
$0.117
最終同期: 2025-04-04
時価総額
$2.45M
変化(1日)
-13.59%
変化(1年)
0.00%
US
取引 Carmell Therapeutics Corporation (CTCX)

カテゴリー

Carmell Therapeutics Corporation(CTCX)の株式分割履歴
Carmell Therapeutics Corporation株(シンボル:CTCX)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 15, 2026に行われました。
Aug 15, 2026より前に購入されたCTCX株は、現在0CTCX株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE